Note: GNS Healthcare's revenues are gauged from an analysis of company filings.
GNS Healthcare's Income Statement (based on Industry Averages)
GNS Healthcare P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
GNS Healthcare has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
April 11, 2019
6
60%
$38 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that GNS Healthcare is developing and marketing.
GNS Healthcare doesn't have any recent trademark applications, indicating GNS Healthcare is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
GEMINI - THE IN SILICO PATIENT Providing temporary use of non-downloadable cloud-based software for simulating and modeling an in silico patient; providing computer modeling services, namely, in silico modeling of disease progression and drug response in the fields of oncology, immunology, neurodegeneration, and cardiometabolic disease; consulting services for others in the field of computer modeling of blood cancer progression and solid tumor progression for use in clinical trial design and pharmaceutical drug development
02/01/2021
GEMINI Providing temporary use of non-downloadable cloud-based software for simulating and modeling an in silico patient; providing computer modeling services, namely, in silico modeling of disease progression and drug response in the fields of oncology, immunology, neurodegeneration, and cardiometabolic disease; consulting services for others in the field of computer modeling of blood cancer progression and solid tumor progression for use in clinical trial design and pharmaceutical drug development; computer modeling services; customizing computer software
08/05/2020
GEMINAI Providing temporary use of non-downloadable cloud-based software for simulating and modeling an in silico patient; providing computer modeling services, namely, in silico modeling of disease progression and drug response in the fields of oncology, immunology, neurodegeneration, and cardiometabolic disease; consulting services for others in the field of computer modeling of blood cancer progression and solid tumor progression for use in clinical trial design and pharmaceutical drug development; computer modeling services; customizing computer software
08/05/2020
See all trademarks and details in the Full Report.
Market Share of GNS Healthcare's Largest Competitors
A competitive analysis shows these companies are in the same general field as GNS Healthcare, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to GNS Healthcare.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as GNS Healthcare and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.